IMU Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - ImmunoGen Inc

Watchlist Manager

Watchlist

Price: 28.9 EUR Market Closed

Market Cap: €1.4B

I	ImmunoGen Inc SWB:IMU	US
M	Metso Oyj XMUN:M6Q	FI
F	Finning International Inc SWB:CIH	CA

Profitability Summary

ImmunoGen Inc's profitability score is 24/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

99%

Strong 3Y Average Gross Margin

95%

Gross Margin is Increasing

75% > 99%

Negative Operating Margin

-28%

Negative 3Y Average Operating Margin

-62%

Operating Margin is Increasing

-199% > -28%

Negative Net Margin

-26%

Negative 3Y Average Net Margin

-61%

Net Margin is Increasing

-199% > -26%

Negative Free Cash Flow Margin

-69%

Negative 3Y Average Free Cash Flow Margin

-105%

Free Cash Flow Margin is Increasing

-218% > -69%

Negative ROE

-20%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-157%

ROIC is Increasing

-582% > -74%

View All

Hide

Collapse

24 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.